ID   AT2B3_RAT               Reviewed;        1258 AA.
AC   Q64568; Q01489; Q63444;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   29-MAY-2024, entry version 187.
DE   RecName: Full=Plasma membrane calcium-transporting ATPase 3;
DE            Short=PMCA3;
DE            EC=7.2.2.10 {ECO:0000305|PubMed:25014339, ECO:0000305|PubMed:9880546};
DE   AltName: Full=Plasma membrane calcium ATPase isoform 3;
DE   AltName: Full=Plasma membrane calcium pump isoform 3;
GN   Name=Atp2b3; Synonyms=Pmca3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZA), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=2530223; DOI=10.1016/s0021-9258(18)51505-2;
RA   Greeb J., Shull G.E.;
RT   "Molecular cloning of a third isoform of the calmodulin-sensitive plasma
RT   membrane Ca2+-transporting ATPase that is expressed predominantly in brain
RT   and skeletal muscle.";
RL   J. Biol. Chem. 264:18569-18576(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1016-1258 (ISOFORMS XF/ZF), AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=CD Charles River;
RX   PubMed=1388171; DOI=10.1016/s0021-9258(18)41829-7;
RA   Burk S.E., Shull G.E.;
RT   "Structure of the rat plasma membrane Ca(2+)-ATPase isoform 3 gene and
RT   characterization of alternative splicing and transcription products.
RT   Skeletal muscle-specific splicing results in a plasma membrane Ca(2+)-
RT   ATPase with a novel calmodulin-binding domain.";
RL   J. Biol. Chem. 267:19683-19690(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1054-1258, ALTERNATIVE SPLICING
RP   (ISOFORMS XA/ZA), AND TISSUE SPECIFICITY (ISOFORMS XA AND XB).
RC   STRAIN=CD Charles River;
RX   PubMed=8428948; DOI=10.1016/s0021-9258(18)53836-9;
RA   Keeton T.P., Burk S.E., Shull G.E.;
RT   "Alternative splicing of exons encoding the calmodulin-binding domains and
RT   C termini of plasma membrane Ca(2+)-ATPase isoforms 1, 2, 3, and 4.";
RL   J. Biol. Chem. 268:2740-2748(1993).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=9880546; DOI=10.1074/jbc.274.3.1667;
RA   Guerini D., Garcia-Martin E., Gerber A., Volbracht C., Leist M.,
RA   Merino C.G., Carafoli E.;
RT   "The expression of plasma membrane Ca2+ pump isoforms in cerebellar granule
RT   neurons is modulated by Ca2+.";
RL   J. Biol. Chem. 274:1667-1676(1999).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17183553; DOI=10.1002/cne.21237;
RA   Burette A., Weinberg R.J.;
RT   "Perisynaptic organization of plasma membrane calcium pumps in cerebellar
RT   cortex.";
RL   J. Comp. Neurol. 500:1127-1135(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; THR-1079 AND SER-1126, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=25014339; DOI=10.1371/journal.pone.0102352;
RA   Boczek T., Lisek M., Ferenc B., Kowalski A., Stepinski D., Wiktorska M.,
RA   Zylinska L.;
RT   "Plasma membrane Ca2+-ATPase isoforms composition regulates cellular pH
RT   homeostasis in differentiating PC12 cells in a manner dependent on
RT   cytosolic Ca2+ elevations.";
RL   PLoS ONE 9:e102352-e102352(2014).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=27035656; DOI=10.1210/en.2015-2029;
RA   Tauber P., Aichinger B., Christ C., Stindl J., Rhayem Y., Beuschlein F.,
RA   Warth R., Bandulik S.;
RT   "Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the
RT   Plasma Membrane Ca(2+)-ATPase ATP2B3.";
RL   Endocrinology 157:2489-2499(2016).
CC   -!- FUNCTION: ATP-driven Ca(2+) ion pump involved in the maintenance of
CC       basal intracellular Ca(2+) levels at the presynaptic terminals. Uses
CC       ATP as an energy source to transport cytosolic Ca(2+) ions across the
CC       plasma membrane to the extracellular compartment (PubMed:25014339,
CC       PubMed:9880546). May counter-transport protons, but the mechanism and
CC       the stoichiometry of this Ca(2+)/H(+) exchange remains to be
CC       established (PubMed:25014339, PubMed:9880546).
CC       {ECO:0000269|PubMed:25014339, ECO:0000269|PubMed:9880546}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + Ca(2+)(in) + H2O = ADP + Ca(2+)(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:18105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29108, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; EC=7.2.2.10;
CC         Evidence={ECO:0000305|PubMed:25014339, ECO:0000305|PubMed:9880546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18106;
CC         Evidence={ECO:0000305|PubMed:25014339, ECO:0000305|PubMed:9880546};
CC   -!- SUBUNIT: Interacts with PDZD11. Interacts (via N-terminus) with YWHAE.
CC       {ECO:0000250|UniProtKB:Q16720}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:27035656};
CC       Multi-pass membrane protein {ECO:0000255}. Presynaptic cell membrane
CC       {ECO:0000269|PubMed:17183553}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Localized at parallel fiber terminals.
CC       {ECO:0000269|PubMed:17183553}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC         Comment=There is a combination of two alternative spliced domains at
CC         N-terminal site A (X and Z) and at C-terminal site C (A, B, C, D, E
CC         and F). So far the splice sites have been studied independently.
CC         Experimental confirmation may be lacking for some isoforms.;
CC       Name=XD; Synonyms=AIICIV;
CC         IsoId=Q64568-1; Sequence=Displayed;
CC       Name=XA; Synonyms=AIICII;
CC         IsoId=Q64568-2; Sequence=VSP_000400;
CC       Name=ZA; Synonyms=AICII;
CC         IsoId=Q64568-3; Sequence=VSP_000396, VSP_000400;
CC       Name=XB; Synonyms=AIICI;
CC         IsoId=Q64568-4; Sequence=VSP_000397;
CC       Name=ZB; Synonyms=AICI;
CC         IsoId=Q64568-5; Sequence=VSP_000396, VSP_000397;
CC       Name=XC; Synonyms=AIICIII;
CC         IsoId=Q64568-6; Sequence=VSP_000399;
CC       Name=ZC; Synonyms=AICIII;
CC         IsoId=Q64568-7; Sequence=VSP_000396, VSP_000399;
CC       Name=ZD; Synonyms=AICIV;
CC         IsoId=Q64568-8; Sequence=VSP_000396;
CC       Name=XE; Synonyms=AIICV;
CC         IsoId=Q64568-9; Sequence=VSP_000401;
CC       Name=ZE; Synonyms=AICV;
CC         IsoId=Q64568-10; Sequence=VSP_000396, VSP_000401;
CC       Name=XF; Synonyms=AIICVI;
CC         IsoId=Q64568-11; Sequence=VSP_000398;
CC       Name=ZF; Synonyms=AICVI;
CC         IsoId=Q64568-12; Sequence=VSP_000396, VSP_000398;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in brain and skeletal
CC       muscle (PubMed:2530223). Expressed in the molecular layer of the
CC       cerebellar cortex, in particular in granule cells (at protein level)
CC       (PubMed:17183553, PubMed:27035656, PubMed:9880546). Expressed in
CC       aldosterone producing glomerulosa cells of adrenal glands (at protein
CC       level) (PubMed:27035656). Detected at low levels in various tissues
CC       including testis, stomach, small intestine, and large intestine
CC       (PubMed:2530223). {ECO:0000269|PubMed:17183553,
CC       ECO:0000269|PubMed:2530223, ECO:0000269|PubMed:27035656,
CC       ECO:0000269|PubMed:9880546}.
CC   -!- TISSUE SPECIFICITY: [Isoform XA]: Most abundant form in brain and most
CC       other tissues. {ECO:0000269|PubMed:8428948}.
CC   -!- TISSUE SPECIFICITY: [Isoform XB]: Most abundant form in skeletal muscle
CC       and is also found in brain and at low levels in testis and kidney.
CC       {ECO:0000269|PubMed:8428948}.
CC   -!- INDUCTION: Up-regulated upon activation of glutamate-operated calcium
CC       channels. {ECO:0000269|PubMed:9880546}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIB subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L05565; AAA53650.1; -; Genomic_DNA.
DR   EMBL; L05558; AAA53650.1; JOINED; Genomic_DNA.
DR   EMBL; L05564; AAA53650.1; JOINED; Genomic_DNA.
DR   EMBL; J05087; AAA69667.1; -; mRNA.
DR   EMBL; M96626; AAA50821.1; -; mRNA.
DR   PIR; A34308; A34308.
DR   PIR; C44525; C44525.
DR   RefSeq; NP_579822.1; NM_133288.1. [Q64568-3]
DR   RefSeq; XP_008771842.1; XM_008773620.2. [Q64568-7]
DR   RefSeq; XP_017457435.1; XM_017601946.1.
DR   RefSeq; XP_017457436.1; XM_017601947.1.
DR   RefSeq; XP_017457437.1; XM_017601948.1.
DR   AlphaFoldDB; Q64568; -.
DR   SMR; Q64568; -.
DR   BioGRID; 248231; 2.
DR   IntAct; Q64568; 1.
DR   MINT; Q64568; -.
DR   STRING; 10116.ENSRNOP00000075088; -.
DR   iPTMnet; Q64568; -.
DR   PhosphoSitePlus; Q64568; -.
DR   SwissPalm; Q64568; -.
DR   jPOST; Q64568; -.
DR   PaxDb; 10116-ENSRNOP00000035695; -.
DR   Ensembl; ENSRNOT00000098998.1; ENSRNOP00000083651.1; ENSRNOG00000061304.2. [Q64568-7]
DR   GeneID; 29599; -.
DR   KEGG; rno:29599; -.
DR   AGR; RGD:621304; -.
DR   CTD; 492; -.
DR   RGD; 621304; Atp2b3.
DR   VEuPathDB; HostDB:ENSRNOG00000061304; -.
DR   eggNOG; KOG0204; Eukaryota.
DR   GeneTree; ENSGT00940000160765; -.
DR   InParanoid; Q64568; -.
DR   OrthoDB; 847at2759; -.
DR   PhylomeDB; Q64568; -.
DR   Reactome; R-RNO-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:Q64568; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000061304; Expressed in cerebellum and 12 other cell types or tissues.
DR   ExpressionAtlas; Q64568; baseline and differential.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:1990032; C:parallel fiber; IDA:UniProtKB.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005388; F:P-type calcium transporter activity; IBA:GO_Central.
DR   GO; GO:1905056; F:P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:1990034; P:calcium ion export across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0003407; P:neural retina development; IEP:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   CDD; cd02081; P-type_ATPase_Ca_PMCA-like; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 2.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR022141; ATP_Ca_trans_C.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR006408; P-type_ATPase_IIB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01517; ATPase-IIB_Ca; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 3.
DR   PANTHER; PTHR24093; CATION TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR24093:SF284; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 3; 1.
DR   Pfam; PF12424; ATP_Ca_trans_C; 2.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 2.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   SFLD; SFLDG00002; C1.7:_P-type_atpase_like; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Cell projection; Ion transport;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Synapse; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1258
FT                   /note="Plasma membrane calcium-transporting ATPase 3"
FT                   /id="PRO_0000046219"
FT   TOPO_DOM        1..97
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..118
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..155
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        156..176
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        177..364
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        365..384
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        385..417
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        418..435
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..849
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        850..869
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        870..879
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        880..900
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        901..920
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        921..943
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        944..961
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        962..983
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        984..1002
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1003..1024
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1025..1034
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1035..1056
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1057..1258
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          298..328
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          335..354
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1097..1114
FT                   /note="Calmodulin-binding subdomain A"
FT                   /evidence="ECO:0000250"
FT   REGION          1115..1124
FT                   /note="Calmodulin-binding subdomain B"
FT                   /evidence="ECO:0000250"
FT   REGION          1204..1258
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        337..354
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1221..1258
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        473
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         794
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         798
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1079
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1113
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         306..319
FT                   /note="Missing (in isoform ZA, isoform ZB, isoform ZC,
FT                   isoform ZD, isoform ZE and isoform ZF)"
FT                   /evidence="ECO:0000303|PubMed:2530223"
FT                   /id="VSP_000396"
FT   VAR_SEQ         1115..1258
FT                   /note="MEVVSTFKRSGSFQGAVRRRSSVLSQLHDVTNLSTPTHIRVVKAFRSSLYEG
FT                   LEKPESKSCIHNFMATPEFLINDYTHNIPLIDDTDVDENEERLRAPPPPPPNQNNNAID
FT                   SGIYLTTHATKSATSSAFSSRPGSPLHSMETSL -> VCWDGKKMLRTTEVG (in
FT                   isoform XF and isoform ZF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000398"
FT   VAR_SEQ         1115..1152
FT                   /note="Missing (in isoform XB and isoform ZB)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000397"
FT   VAR_SEQ         1144..1152
FT                   /note="Missing (in isoform XC and isoform ZC)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000399"
FT   VAR_SEQ         1153..1258
FT                   /note="IRVVKAFRSSLYEGLEKPESKSCIHNFMATPEFLINDYTHNIPLIDDTDVDE
FT                   NEERLRAPPPPPPNQNNNAIDSGIYLTTHATKSATSSAFSSRPGSPLHSMETSL -> V
FT                   TLSAAKPTSAAGNPSGESIP (in isoform XA and isoform ZA)"
FT                   /evidence="ECO:0000303|PubMed:2530223"
FT                   /id="VSP_000400"
FT   VAR_SEQ         1153..1258
FT                   /note="IRVVKAFRSSLYEGLEKPESKSCIHNFMATPEFLINDYTHNIPLIDDTDVDE
FT                   NEERLRAPPPPPPNQNNNAIDSGIYLTTHATKSATSSAFSSRPGSPLHSMETSL -> V
FT                   TLSAAKPTSAAGSES (in isoform XE and isoform ZE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000401"
SQ   SEQUENCE   1258 AA;  138559 MW;  3A13781D21042BA6 CRC64;
     MGDMANSSIE FHPKPQQQRE VPHVGGFGCT LAELRSLMEL RGAEALQKIQ EAYGDVSGLC
     RRLKTSPTEG LADNTNDLEK RRQIYGQNFI PPKQPKTFLQ LVWEALQDVT LIILEVAAIV
     SLGLSFYAPP GEESEACGNV SGGAEDEGEA EAGWIEGAAI LLSVICVVLV TAFNDWSKEK
     QFRGLQSRIE QEQKFTVIRN GQLLQVPVAA LVVGDIAQVK YGDLLPADGV LIQGNDLKID
     ESSLTGESDH VRKSADKDPM LLSGTHVMEG SGRMVVTAVG VNSQTGIIFT LLGAGGEEEE
     KKDKKGKQQD GAMESSQTKA KKQDGAVAME MQPLKSAEGG EMEEREKKKA NVPKKEKSVL
     QGKLTKLAVQ IGKAGLVMSA ITVIILVLYF VIETFVVDGR VWLAECTPVY VQYFVKFFII
     GVTVLVVAVP EGLPLAVTIS LAYSVKKMMK DNNLVRHLDA CETMGNATAI CSDKTGTLTT
     NRMTVVQSYL GDTHYKEIPA PSALTPKILD LLVHAISINS AYTTKILPPE KEGALPRQVG
     NKTECALLGF ILDLKRDFQP VREQIPEDQL YKVYTFNSVR KSMSTVIRMP DGGFRLFSKG
     ASEILLKKCT NILNSNGELR GFRPRDRDDM VKKIIEPMAC DGLRTICIAY RDFSAIQEPD
     WDNENEVVGD LTCIAVVGIE DPVRPEVPEA IRKCQRAGIT VRMVTGDNIN TARAIAAKCG
     IIQPGEDFLC LEGKEFNRRI RNEKGEIEQE RLDKVWPKLR VLARSSPTDK HTLVKGIIDS
     TTGEQRQVVA VTGDGTNDGP ALKKADVGFA MGIAGTDVAK EASDIILTDD NFTSIVKAVM
     WGRNVYDSIS KFLQFQLTVN VVAVIVAFTG ACITQDSPLK AVQMLWVNLI MDTFASLALA
     TEPPTESLLL RKPYGRDKPL ISRTMMKNIL GHAVYQLTII FTLLFVGELF FDIDSGRNAP
     LHSPPSEHYT IIFNTFVMMQ LFNEINARKI HGERNVFDGI FSNPIFCTIV LGTFGIQIVI
     VQFGGKPFSC SPLSTEQWLW CLFVGVGELV WGQVIATIPT SQLKCLKEAG HGPGKDEMTD
     EELAEGEEEI DHAERELRRG QILWFRGLNR IQTQMEVVST FKRSGSFQGA VRRRSSVLSQ
     LHDVTNLSTP THIRVVKAFR SSLYEGLEKP ESKSCIHNFM ATPEFLINDY THNIPLIDDT
     DVDENEERLR APPPPPPNQN NNAIDSGIYL TTHATKSATS SAFSSRPGSP LHSMETSL
//
